Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Katie Couric Discusses "celebrity Weight Loss Drug," Ozempic With Obesity Expert And Dr. Lou Aronne Semaglutide
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-29
Katie Couric interviews Dr. Lou Aronne, an expert on obesity and a physician at New York Hospital, on what everyone’s describing as the “celebrity weight loss drug”, Ozempic -- including how it works, and who should (and shouldn't) be taking it.
Subscribe to my channel:
Follow me on Instagram:
Subscribe to my podcast: ApplePodcasts.com/KatieCouric
Follow me on Facebook:
Follow me on Twitter:
Katie Couric Discusses "celebrity Weight Loss Drug," Ozempic With Obesity Expert And Dr. Lou Aronne For Country: United States. City: Ann Arbor, Chicago, Dallas, Huntington Beach, Kent
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication